Results 1 to 10 of about 98,812 (291)
Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke? [PDF]
Hypertriglyceridemia is caused by defects in triglyceride metabolism and generally manifests as abnormally high plasma triglyceride levels. Although the role of hypertriglyceridemia may not draw as much attention as that of plasma cholesterol in stroke ...
Hai-jie Liang+4 more
doaj +2 more sources
Objectives:. To report the prevalence of, and evaluate risk factors for, the development of hypertriglyceridemia (defined as a serum triglyceride level of > 400 mg/dL) in patients with coronavirus disease 2019 who received propofol. Design:.
Mary P. Kovacevic, PharmD, BCCCP, BCPS+4 more
doaj +2 more sources
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
Plasma lipoprotein concentration, composition, and size were evaluated in two common familial forms of hypertriglyceridemia and compared with those in normal subjects.
J D Brunzell+5 more
doaj +2 more sources
Background Hypertension and high triglyceride are two of the most important risk factors for hyperuricemia. Epidemiological records show that hypertension and dyslipidemia often coexist and may significantly increase the risk of target organ damage ...
Yuan Zhang+8 more
doaj +2 more sources
LESS IS MORE: classified management of hypertriglyceridemia-induced acute pancreatitis on the basis of a propensity score matching cohort study [PDF]
Background Effective management of hypertriglyceridemia is crucial in the treatment of hypertriglyceridemia-induced acute pancreatitis (HTG-AP). The prognosis of HTG-AP may vary with different serum triglyceride levels, suggesting the need for stratified
Pan Tan+7 more
doaj +2 more sources
Mechanisms linking hypertriglyceridemia to acute pancreatitis
Hypertriglyceridemia (HTG) is a metabolic disorder, defined when serum or plasma triglyceride concentration (seTG) is >1.7 mM. HTG can be categorized as mild to very severe groups based on the seTG value.
L. Kiss+6 more
semanticscholar +1 more source
The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial
Pegozafermin, a long-acting glycopegylated analog of human fibroblast growth factor 21, is in development for the treatment of severe hypertriglyceridemia (SHTG) and nonalcoholic steatohepatitis.
D. Bhatt+13 more
semanticscholar +1 more source
Updates in Drug Treatment of Severe Hypertriglyceridemia
Purpose of Review To provide an insight into the new pharmacological options for the treatment of severe hypertriglyceridemia (sHTG). Recent Findings sHTG is difficult to treat.
I. Gouni-Berthold+2 more
semanticscholar +1 more source
Introduction: The objective of this study was to investigate changes in serum lipids among HIV-infected patients switching from non-nucleoside-reverse transcriptase inhibitors (NNRTI) to protease inhibitor (PI)-based highly active antiretroviral therapy
Yu Zhang+8 more
doaj +1 more source
Transient infantile hypertriglyceridemia is a rare autosomal recessive disorder characterized by hypertriglyceridemia, hypohepatia, hepatomegaly, hepatic steatosis and fibrosis in infancy.
Haihua Lin+5 more
doaj +1 more source